Place of sulfonylureas in the management of type 2 diabetes mellitus in South Asia: A consensus statement
نویسندگان
چکیده
Since their introduction in clinical practice in the 1950's, Sulfonylureas (SUs) have remained the main-stay of pharmacotherapy in the management of type 2 diabetes. Despite their well-established benefits, their place in therapy is inappropriately being overshadowed by newer therapies. Many of the clinical issues associated with the use of SUs are agent-specific, and do not pertain to the class as such. Modern SUs (glimepiride, gliclazide MR) are backed by a large body of evidence, experience, and most importantly, outcome data, which supports their role in managing patients with diabetes. Person-centred care, i.e., careful choice of SU, appropriate dosage, timing of administration, and adequate patient counseling, will ensure that deserving patients are not deprived of the advantages of this well-established class of anti-diabetic agents. Considering their efficacy, safety, pleiotropic benefits, and low cost of therapy, SUs should be considered as recommended therapy for the treatment of diabetes in South Asia. This initiative by SAFES aims to encourage rational, safe and smart prescription of SUs, and includes appropriate medication counseling.
منابع مشابه
Safe and pragmatic use of sodium–glucose co-transporter 2 inhibitors in type 2 diabetes mellitus: South Asian Federation of Endocrine Societies consensus statement
Diabetes prevalence shows a continuous increasing trend in South Asia. Although well-established treatment modalities exist for type 2 diabetes mellitus (T2DM) management, they are limited by their side effect profile. Sodium-glucose co-transporter 2 inhibitors (SGLT2i) with their novel insulin-independent renal action provide improved glycemic control, supplemented by reduction in weight and b...
متن کاملPharmacogenomics of glibenclamide in patients with type 2 diabetes mellitus: A systematic review
Introduction: One of the most widely used anti-diabetic drugs is sulfonylureas, which is often used as one of the first-line drugs in the treatment of type 2 diabetes. Due to the effect of the patient's genetic structure on the drug response (personalized medicine), the identification of genetic variations not only reduces the rate of adverse drug reactions but can also predict the effectivenes...
متن کاملThe effect of educational intervention on depression in patients with type 2 diabetes
1. Shahsavari A, Foroghi S. Effectiveness of cognitive therapy on depression in epileptic patients. ijpn. 2015;3(1):37-46. 2. Anonamous. Diabetes. WHO [Internet]. http://www. who.int/news-room/fact-sheet s/detai l/diabe tes. 2018 [updated 30 Oct 2018]. 3.Guariguata L, Whiting DR, Hambleton I, Beagley J, Linnenkamp U, Shaw JE. Global estimates of diabetes prevalence for 2013 and projections fo...
متن کاملTrends in the Prevalence of Diabetes Mellitus in Patients with Myocardial Infarction in the South of Iran: 2008 to 2014
Background: Diabetes mellitus is a strong risk factor for cardiovascular disease, including acute myocardial infarction (AMI). Management of risk factors and the other prevention services in recent years lead to a significant decrease in AMI incidence. However, to examine the success of those strategies to control diabetes, this study aimed to identify the trends in prevalence of diabetes melli...
متن کاملBirth Weight and Childhood Onset Type 1 Diabetes: A Case-Control Study in Shiraz, South of Iran
To determine the relation between birth weight and age of presentation of type 1 diabetes and assess its risk factors, a case-control study was done on all diabetic patients under the age of 15, who were registered in Shiraz Diabetic Center or admitted in Namazi Hospital. A case group of 87 diabetic patients were matched with a control group of 100 healthy individuals. Birth weight ≥ 4kg was de...
متن کامل